Overview

Study to Detect Oral Administration of Budesonide in Women.

Status:
Completed

Trial end date:
2018-09-10

Target enrollment:

Participant gender:

Summary

This study aims at identifying analysis strategies to detect oral administration of Budesonide in women; in order for them to be used by the accredited laboratories of the Worl Anti-Doping Agency (WADA).

Phase:

Phase 1

Details

Lead Sponsor:

Parc de Salut Mar

Treatments:

Budesonide